These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11369880)

  • 21. Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo.
    Mikkelsen JG; Lund AH; Duch M; Pedersen FS
    J Virol; 2000 Jan; 74(2):600-10. PubMed ID: 10623721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of regulated LTR-mediated expression.
    Lorens JB; Jang Y; Rossi AB; Payan DG; Bogenberger JM
    Virology; 2000 Jun; 272(1):7-15. PubMed ID: 10873744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering of alfalfa mosaic virus RNA 3 into an expression vector.
    Sanchez-Navarro J; Miglino R; Ragozzino A; Bol JF
    Arch Virol; 2001; 146(5):923-39. PubMed ID: 11448030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
    Kung SK; An DS; Chen IS
    J Virol; 2000 Apr; 74(8):3668-81. PubMed ID: 10729143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping the rubella virus subgenomic promoter.
    Tzeng WP; Frey TK
    J Virol; 2002 Apr; 76(7):3189-201. PubMed ID: 11884543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes.
    Gladow M; Becker C; Blankenstein T; Uckert W
    J Gene Med; 2000; 2(6):409-15. PubMed ID: 11199261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cis-acting elements required for strong stop acceptor template selection during Moloney murine leukemia virus reverse transcription.
    Topping R; Demoitie MA; Shin NH; Telesnitsky A
    J Mol Biol; 1998 Aug; 281(1):1-15. PubMed ID: 9680471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retroviral vectors for high-level transgene expression in T lymphocytes.
    Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
    Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for retroviral intramolecular recombinations.
    Zhang J; Ma Y
    J Virol; 2001 Jul; 75(14):6348-58. PubMed ID: 11413301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of YB-1 enhances production of murine leukemia virus vectors by stabilizing genomic viral RNA.
    Li W; Wang X; Gao G
    Protein Cell; 2012 Dec; 3(12):943-9. PubMed ID: 23225179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus.
    Torrent C; Bordet T; Darlix JL
    J Mol Biol; 1994 Jul; 240(5):434-44. PubMed ID: 8046749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-mediated targeting of replication-competent retroviral vectors.
    Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
    Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
    Lee SK; Nagashima K; Hu WS
    J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput gateway bicistronic retroviral vectors for stable expression in mammalian cells: exploring the biologic effects of STAT5 overexpression.
    Royer Y; Menu C; Liu X; Constantinescu SN
    DNA Cell Biol; 2004 Jun; 23(6):355-65. PubMed ID: 15231069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus vector carries a foreign gene into liver cells in vitro.
    Yoo J; Rho J; Lee D; Shin S; Jung G
    Virus Genes; 2002 Jun; 24(3):215-24. PubMed ID: 12086141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral vectors to monitor somatic hypermutation.
    Klasen M; Spillmann FJ; Lorens JB; Wabl M
    J Immunol Methods; 2005 May; 300(1-2):47-62. PubMed ID: 15936027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates.
    Onafuwa A; An W; Robson ND; Telesnitsky A
    J Virol; 2003 Apr; 77(8):4577-87. PubMed ID: 12663764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From retroviral vector production to gene transfer: spontaneous inactivation is caused by loss of reverse transcription capacity.
    Carmo M; Panet A; Carrondo MJ; Alves PM; Cruz PE
    J Gene Med; 2008 Apr; 10(4):383-91. PubMed ID: 18240154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.
    Hlavaty J; Stracke A; Klein D; Salmons B; Günzburg WH; Renner M
    J Virol; 2004 Feb; 78(3):1384-92. PubMed ID: 14722293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral transduction of oncogenic sequences involves viral DNA instead of RNA.
    Goodrich DW; Duesberg PH
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3733-7. PubMed ID: 2836857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.